298 related articles for article (PubMed ID: 24667352)
1. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
[TBL] [Abstract][Full Text] [Related]
2. Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach.
Fanis P; Kousiappa I; Phylactides M; Kleanthous M
BMC Genomics; 2014 Feb; 15():108. PubMed ID: 24502199
[TBL] [Abstract][Full Text] [Related]
3. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.
Bitoungui VJ; Ngogang J; Wonkam A
Blood Cells Mol Dis; 2015 Mar; 54(3):268-9. PubMed ID: 25488618
[No Abstract] [Full Text] [Related]
5. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
7. Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.
Mikobi TM; Tshilobo Lukusa P; Aloni MN; Lumaka AZ; Kaba DK; Devriendt K; Matthijs G; Mbuyi Muamba JM; Race V
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28332727
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients.
Lai Y; Chen Y; Chen B; Zheng H; Yi S; Li G; Wei H; He S; Zheng C
Hemoglobin; 2016 Nov; 40(6):405-410. PubMed ID: 28361591
[TBL] [Abstract][Full Text] [Related]
9. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
11. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
[TBL] [Abstract][Full Text] [Related]
12. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
[TBL] [Abstract][Full Text] [Related]
13. The genetics of hemoglobin A2 regulation in sickle cell anemia.
Griffin PJ; Sebastiani P; Edward H; Baldwin CT; Gladwin MT; Gordeuk VR; Chui DH; Steinberg MH
Am J Hematol; 2014 Nov; 89(11):1019-23. PubMed ID: 25042611
[TBL] [Abstract][Full Text] [Related]
14. Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
Upadhye D; Jain D; Trivedi Y; Nadkarni A; Ghosh K; Colah R
Ann Hematol; 2016 Jun; 95(7):1201-3. PubMed ID: 27098811
[No Abstract] [Full Text] [Related]
15. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
[No Abstract] [Full Text] [Related]
16. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
[TBL] [Abstract][Full Text] [Related]
17. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
[TBL] [Abstract][Full Text] [Related]
18. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
[TBL] [Abstract][Full Text] [Related]
19. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
[TBL] [Abstract][Full Text] [Related]
20. Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients.
Bhanushali AA; Patra PK; Nair D; Verma H; Das BR
Blood Cells Mol Dis; 2015 Jan; 54(1):4-8. PubMed ID: 25457385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
